Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Osteoporosis

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 78 articles: HTML format Text format

Single Articles

February 2012
1. MAJUMDAR SR , Lix LM, Yogendran M, Morin SN, et al
   Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998-2008).
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
2. MAJUMDAR SR , Ezekowitz JA, Lix LM, Leslie WD, et al
   Heart Failure Is a Clinically and Densitometrically Independent Risk Factor for Osteoporotic Fractures: Population-Based Cohort Study of 45,509 Subjects.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. BREDELLA MA , Fazeli PK, Freedman LM, Calder G, et al
   Young Women with Cold-Activated Brown Adipose Tissue Have Higher Bone Mineral Density and Lower Pref-1 than Women without Brown Adipose Tissue: A Study in Women with Anorexia Nervosa, Women Recovered from Anorexia Nervosa, and Normal-Weight Women.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. BARON R , Hesse E
   Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. LIU JM , Ma LY, Bi YF, Xu Y, et al
   A Population-Based Study Examining Calcaneus Quantitative Ultrasound and Its Optimal Cut-Points to Discriminate Osteoporotic Fractures among 9352 Chinese Women and Men.
   J Clin Endocrinol Metab. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. YIN MT , Zhang CA, McMahon DJ, Ferris DC, et al
   Higher Rates of Bone Loss in Postmenopausal HIV-Infected Women: A Longitudinal Study.
   J Clin Endocrinol Metab. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
7. SCHAFER AL , Sellmeyer DE, Schwartz AV, Rosen CJ, et al
   Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Postmenopausal Women with Osteoporosis (the PaTH Study).
   J Clin Endocrinol Metab. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KOETZ KR , Ventz M, Diederich S, Quinkler M, et al
   Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy.
   J Clin Endocrinol Metab. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. NIRAMITMAHAPANYA S , Harris SS, Dawson-Hughes B
   Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation.
   J Clin Endocrinol Metab. 2011;96:3170-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
10. ZEMEL BS , Kalkwarf HJ, Gilsanz V, Lappe JM, et al
    Revised Reference Curves for Bone Mineral Content and Areal Bone Mineral Density According to Age and Sex for Black and Non-Black Children: Results of the Bone Mineral Density in Childhood Study.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. HAUGEN B , Hennessey JV, Wartofsky L
    Bifosfonatos para la osteoporosis: Beneficios y riesgos.
    J Clin Endocrinol Metab. 2011;96:28A.
    PubMed     Text format     Related articles   
    
    
    
    
12. BOLLERSLEV J , Harris ST, Leder BZ
    Bisphosphonates for osteoporosis: benefits and risks.
    J Clin Endocrinol Metab. 2011;96:27A.
    PubMed     Text format     Related articles   
    
    
    
    
13. FRERIKS K , Timmermans J, Beerendonk CC, Verhaak CM, et al
    Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome.
    J Clin Endocrinol Metab. 2011;96:E1517-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. BOLLAND MJ , Wang TK, Grey A, Gamble GD, et al
    Stable bone density in HAART-treated individuals with HIV: a meta-analysis.
    J Clin Endocrinol Metab. 2011;96:2721-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
15. EASTELL R , Hannon RA, Wenderoth D, Rodriguez-Moreno J, et al
    Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. COHEN A , Dempster DW, Recker RR, Stein EM, et al
    Abnormal Bone Microarchitecture and Evidence of Osteoblast Dysfunction in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. PREMAOR MO , Ensrud K, Lui L, Parker RA, et al
    Risk factors for nonvertebral fracture in obese older women.
    J Clin Endocrinol Metab. 2011;96:2414-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
18. ARONIS KN , Kilim H, Chamberland JP, Breggia A, et al
    Preadipocyte Factor-1 Levels Are Higher in Women with Hypothalamic Amenorrhea and Are Associated with Bone Mineral Content and Bone Mineral Density through a Mechanism Independent of Leptin.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. BIVER E , Salliot C, Combescure C, Gossec L, et al
    Influence of Adipokines and Ghrelin on Bone Mineral Density and Fracture Risk: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CARVALHO NN , Voss LA, Almeida MO, Salgado CL, et al
    Atypical Femoral Fractures during Prolonged Use of Bisphosphonates: Short-Term Responses to Strontium Ranelate and Teriparatide.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. PATRICK AR , Schousboe JT, Losina E, Solomon DH, et al
    The Economics of Improving Medication Adherence in Osteoporosis: Validation and Application of a Simulation Model.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. BOYCE AM , Gafni RI
    Approach to the child with fractures.
    J Clin Endocrinol Metab. 2011;96:1943-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
23. FITZPATRICK LA , Dabrowski CE, Cicconetti G, Gordon DN, et al
    The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bone Mineral Density.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
24. MILLER KK , Meenaghan E, Lawson EA, Misra M, et al
    Effects of Risedronate and Low-Dose Transdermal Testosterone on Bone Mineral Density in Women with Anorexia Nervosa: A Randomized, Placebo-Controlled Study.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. TSOURDI E , Rachner TD, Gruber M, Hamann C, et al
    Seizures Associated with Zoledronic Acid for Osteoporosis.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. STEIN EM , Liu XS, Nickolas TL, Cohen A, et al
    Abnormal Microarchitecture and Stiffness in Postmenopausal Women with Ankle Fractures.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. BINKLEY N , Gemar D, Engelke J, Gangnon R, et al
    Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.
    J Clin Endocrinol Metab. 2011;96:981-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KUKULJAN S , Nowson CA, Sanders KM, Nicholson GC, et al
    Independent and combined effects of calcium-vitamin D3 and exercise on bone structure and strength in older men: an 18-month factorial design randomized controlled trial.
    J Clin Endocrinol Metab. 2011;96:955-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
29. GOMBERG SJ , Wustrack RL, Napoli N, Arnaud CD, et al
    Teriparatide, Vitamin D, and Calcium Healed Bilateral Subtrochanteric Stress Fractures in a Postmenopausal Woman with a 13-Year History of Continuous Alendronate Therapy.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. BOURS SP , van Geel TA, Geusens PP, Janssen MJ, et al
    Contributors to Secondary Osteoporosis and Metabolic Bone Diseases in Patients Presenting with a Clinical Fracture.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BOONEN S , Adachi JD, Man Z, Cummings SR, et al
    Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. GATTI D , Viapiana O, Idolazzi L, Fracassi E, et al
    The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. TRITOS NA , Greenspan SL, King D, Hamrahian A, et al
    Unreplaced Sex Steroid Deficiency, Corticotropin Deficiency, and Lower IGF-I Are Associated with Lower Bone Mineral Density in Adults with Growth Hormone Deficiency: A KIMS Database Analysis.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MARIE PJ , Kassem M
    Extrinsic mechanisms involved in age-related defective bone formation.
    J Clin Endocrinol Metab. 2011;96:600-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
35. MITCHELL BD , Yerges-Armstrong LM
    The Genetics of Bone Loss: Challenges and Prospects.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. VADIVELOO T , Donnan PT, Cochrane L, Leese GP, et al
    The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients with Endogenous Subclinical Hyperthyroidism.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. CENTER JR , Bliuc D, Nguyen ND, Nguyen TV, et al
    Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. BONE HG , Bolognese MA, Yuen CK, Kendler DL, et al
    Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. RARIY CM , Ratcliffe SJ, Weinstein R, Bhasin S, et al
    Higher Serum Free Testosterone Concentration in Older Women Is Associated with Greater Bone Mineral Density, Lean Body Mass, and Total Fat Mass: the Cardiovascular Health Study.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. HOFFMAN AR , Melmed S, Schlechte J
    Patient guide to hyperprolactinemia diagnosis and treatment.
    J Clin Endocrinol Metab. 2011;96:35A-6A.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
41. FORESTA C , Strapazzon G, De Toni L, Perilli L, et al
    Bone Mineral Density and Testicular Failure: Evidence for a Role of Vitamin D 25-Hydroxylase in Human Testis.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. WHITE HD , Ahmad AM, Durham BH, Joshi AA, et al
    Effect of Oral Phosphate and Alendronate on Bone Mineral Density When Given as Adjunctive Therapy to Growth Hormone Replacement in Adult Growth Hormone Deficiency.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
43. MILLER PD , Wagman RB, Peacock M, Lewiecki EM, et al
    Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BAUER DC
    Bisphosphonate use and atypical femoral fractures: getting down to brass tacks.
    J Clin Endocrinol Metab. 2010;95:5207-9.
    PubMed     Text format     Related articles   
    
    
    
    
45. ROSEN CJ , Manson JE
    Frailty: a D-ficiency syndrome of aging?
    J Clin Endocrinol Metab. 2010;95:5210-2.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
46. ARLT W , Willis DS, Wild SH, Krone N, et al
    Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients.
    J Clin Endocrinol Metab. 2010;95:5110-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
47. REID IR , Gamble GD, Mesenbrink P, Lakatos P, et al
    Characterization of and risk factors for the acute-phase response after zoledronic acid.
    J Clin Endocrinol Metab. 2010;95:4380-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
48. WILLEMSE PM , Hamdy NA, van Wulften L, van Steijn-van Tol AQ, et al
    Prevalence of Vertebral Fractures Independent of BMD and Anticancer Treatment in Patients with Testicular Germ Cell Tumors.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. MEIER C , Brauchli YB, Jick SS, Kraenzlin ME, et al
    Use of Depot Medroxyprogesterone Acetate and Fracture Risk.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. KHOSLA S
    Update on estrogens and the skeleton.
    J Clin Endocrinol Metab. 2010;95:3569-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. ROTHENBUHLER A , Marchand I, Bougneres P, Linglart A, et al
    Risk of corrected QT interval prolongation after pamidronate infusion in children.
    J Clin Endocrinol Metab. 2010;95:3768-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
52. KOCKS J , Ward K, Mughal Z, Moncayo R, et al
    Z-Score Comparability of Bone Mineral Density Reference Databases for Children.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. SCHAFER AL , Vittinghoff E, Lang TF, Sellmeyer DE, et al
    Fat Infiltration of Muscle, Diabetes, and Clinical Fracture Risk in Older Adults.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. KAJI H , Yamauchi M, Yamaguchi T, Shigematsu T, et al
    Mild Renal Dysfunction Is a Risk Factor for a Decrease in Bone Mineral Density and Vertebral Fractures in Japanese Postmenopausal Women.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. DRAKE MT , Srinivasan B, Modder UI, Peterson JM, et al
    Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. LONG DN , Levine MA, Germain-Lee EL
    Bone Mineral Density in Pseudohypoparathyroidism Type 1a.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
57. CAULEY JA , Ewing SK, Taylor BC, Fink HA, et al
    Sex Steroid Hormones in Older Men: Longitudinal Associations with 4.5-Year Change in Hip Bone Mineral Density--The Osteoporotic Fractures in Men Study.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. LIU JM , Zhang MJ, Zhao L, Cui B, et al
    Analysis of Recently Identified Osteoporosis Susceptibility Genes in Han Chinese Women.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. PATERNOSTER L , Ohlsson C, Sayers A, Vandenput L, et al
    OPG and RANK Polymorphisms Are Both Associated with Cortical Bone Mineral Density: Findings from a Metaanalysis of the Avon Longitudinal Study of Parents and Children and Gothenburg Osteoporosis and Obesity Determinants Cohorts.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. GALLAGHER JC , Sai AJ
    Vitamin D insufficiency, deficiency, and bone health.
    J Clin Endocrinol Metab. 2010;95:2630-3.
    PubMed     Text format     Related articles   
    
    
    
    May 2010
61. PATRICK AR , Brookhart MA, Losina E, Schousboe JT, et al
    The Complex Relation between Bisphosphonate Adherence and Fracture Reduction.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
62. MURPHY E , Gluer CC, Reid DM, Felsenberg D, et al
    Thyroid Function within the Upper Normal Range Is Associated with Reduced Bone Mineral Density and an Increased Risk of Nonvertebral Fractures in Healthy Euthyroid Postmenopausal Women.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. TOURNIS S , Michopoulou E, Fatouros IG, Paspati I, et al
    Effect of Rhythmic Gymnastics on Volumetric Bone Mineral Density and Bone Geometry in Premenarcheal Female Athletes and Controls.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. DUNCAN EL , Brown MA
    Genetic Determinants of Bone Density and Fracture Risk--State of the Art and Future Directions.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. CANALIS E
    Update in new anabolic therapies for osteoporosis.
    J Clin Endocrinol Metab. 2010;95:1496-504.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
66. MELHUS H , Snellman G, Gedeborg R, Byberg L, et al
    Plasma 25-Hydroxyvitamin D Levels and Fracture Risk in a Community-Based Cohort of Elderly Men in Sweden.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. GAUDIO A , Pennisi P, Bratengeier C, Torrisi V, et al
    Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SOWERS MR , Zheng H, Jannausch ML, McConnell D, et al
    Amount of Bone Loss in Relation to Time around the Final Menstrual Period and Follicle-Stimulating Hormone Staging of the Transmenopause.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. RUDANG R , Ohlsson C, Oden A, Johansson H, et al
    Hip fracture prevalence in grandfathers is associated with reduced cortical cross-sectional bone area in their young adult grandsons.
    J Clin Endocrinol Metab. 2010;95:1105-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
70. WATTS NB , Diab DL
    Long-Term Use of Bisphosphosphonates in Osteoporosis.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. FINKELSTEIN JS , Wyland JJ, Lee H, Neer RM, et al
    Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. KOLLER DL , Ichikawa S, Lai D, Padgett LR, et al
    Genome-Wide Association Study of Bone Mineral Density in Premenopausal European-American Women and Replication in African-American Women.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. CARNEIRO RM , Prebehalla L, Tedesco MB, Sereika SM, et al
    Lactation and Bone Turnover: A Conundrum of Marked Bone Loss in the Setting of Coupled Bone Turnover.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. BOLLAND MJ , Grey A
    Disparate Outcomes from Applying U.K. and U.S. Osteoporosis Treatment Guidelines.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
75. BOLLAND MJ , Grey AB, Gamble GD, Reid IR, et al
    Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. HORWITZ MJ , Tedesco MB, Garcia-Ocana A, Sereika SM, et al
    Parathyroid Hormone-Related Protein for the Treatment of Postmenopausal Osteoporosis: Defining the Maximal Tolerable Dose.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. KHOSLA S
    Update in male osteoporosis.
    J Clin Endocrinol Metab. 2010;95:3-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2009
78. FLYNN RW , Bonellie SR, Jung RT, Macdonald TM, et al
    Serum Thyroid-Stimulating Hormone Concentration and Morbidity from Cardiovascular Disease and Fractures in Patients on Long-Term Thyroxine Therapy.
    J Clin Endocrinol Metab. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: